reviewDrugsAug 11, 2023GREEN OA

Delandistrogene Moxeparvovec: First Approval

SMSheridan M. Hoy

Springer Nature (New Zealand)

PubMed
Indexed incrossrefdatacitepubmed

Abstract

No abstract available for this paper.

Citation impact

188
total citations
FWCI
27.40
Percentile
100%
References
13
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Medicine
  • Duchenne muscular dystrophy
  • Dystrophin
  • Ambulatory
  • Genetic enhancement
  • Muscular dystrophy
  • Internal medicine
  • Bioinformatics
No related works found for this paper.